Emerson’s Michalle Adkins will be discussing villains and heroes in knowledge management at the fully digital November 2-6, 2020 ISPE Annual Meeting and Expo.
Improving Product and Process Development in Life Sciences
read more
Michalle Adkins
Accelerate Technology Transfer through the Product Development Pipeline
Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
BioPhorum Collaboration for Improving Biopharmaceutical Manufacturing
Emerson’s Michalle Adkins, Benjamin Arriola & Brandon Haschke are co-authors along with professionals in leading biopharmaceutical manufacturing and suppliers in the BioPhorum work, In-line monitoring / real-time release testing in biopharmaceutical processes – prioritization and cost benefit analysis.
BioPhorum Best Practices on Knowledge Management
Emerson’s Michalle Adkins alerted me to the release of a new BioPhorum Knowledge Management white paper, A Test Case in CMC Business Processes from Late-Stage Development to Commercial Manufacturing.
Biopharmaceutical Product and Process Knowledge Management
For biopharmaceutical producers, creating value from the knowledge capture and dissemination is paramount. At the upcoming February 23-26 IFPAC [International Foundation Process Analytical Chemistry] conference, Emerson’s Michalle Adkins will present on the impact of KM in product and process development for biopharmaceutical manufacturers.
Innovating to Meet Bioprocessing Single-Use Requirements
Suppliers to the industry have been innovating to meet the single-use requirements of biotech manufacturers. Emerson’s Michalle Adkins pointed me to a recent award received for technology innovation for these single-use requirements.
BioPhorum Roadmap for In-line Monitoring and Real-time Release
Emerson’s Michalle Adkins will be presenting, Update on BioPhorum’s Roadmap for In-line Monitoring and Real- Time Release at the conference.
Biopharmaceutical Single Use Measurement and Control
At this past autumn’s Emerson Exchange conference in San Antonio, Texas, Emerson’s Michalle Adkins demonstrated single use manufacturing measurement and control devices and how they could be used to measure and control biomanufacturing operations in a single use environment.
Tracking Cell Therapy Chain of Identity
In this 2:25 YouTube video, Address Cell Therapy Batch Production Challenges with Syncade, Emerson’s Michalle Adkins shares how operations management technology plays an important role in addressing these challenges.
Moving to Electronic Batch Records
Yesterday we highlighted advancements in exception management technology for pharmaceutical and biopharmaceutical manufacturers. Exception management is one element in an electronic batch record (EBR). Other elements for the EBR which also have high data integrity...
Technology Trends for Life Sciences Manufacturers
We seem to be fully in the swing of industry conferences. This week is the pharmaceutical and biotech manufacturing industries' INTERPHEX conference in New York City. It: …brings over 11,000 global industry professionals and 650+ leading suppliers together to "Learn...
Data Integrity for Pharmaceutical and Biotech Manufacturers
Update: This post has been updated with a link to the most recent Medicines & Healthcare products Regulatory Agency (MHRA) ‘GXP’ Data Integrity Guidance and Definitions - March 2018 document. For pharmaceutical, biotech and other manufacturers in highly-regulated...
Stay up to Date with the Latest News and Updates
Subscribe for Updates
Follow Us
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Want to re-purpose, reuse or translate content?
Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.